Indications for: NETSPOT
For use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs).
Adults and Children:
See full labeling. Give 2MBq/kg (0.054mCi/kg) up to 200MBq (5.4mCi), as a single IV bolus inj. Starting 40–90mins after IV inj, acquire PET image. The radiation absorbed dose from 150MBq (4.05mCi) dose is 3.15mSv.
Ensure adequate hydration. Risk of radiation exposure. Should only be used by trained and experienced physicians in the safe use and handling of radionuclides to minimize radiation exposure. Risk for image misinterpretation and other errors. Pregnancy. Nursing mothers: interrupt for 12hrs after Netspot exposure.
Radioactive diagnostic agent.
Concomitant long-acting somatostatin analogs: image with Netspot PET just prior to analog dosing. Concomitant short-acting somatostatin analogs: may be used up to 24hrs prior to imaging with Netspot.
Nausea, vomiting, inj site pain, burning sensation.
Generic Drug Availability:
Single-dose kit—1 (reaction vial w. lyophilized pwd + buffer vial)